Format

Send to

Choose Destination
Nat Rev Cancer. 2006 Feb;6(2):130-40.

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.

Author information

1
Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, Washington 98109, USA. nulrich@fhcrc.org

Abstract

Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) show indisputable promise as chemopreventive agents. Possible targets include cancers of the colon, stomach, breast and lung. However, recent studies raise concern about potential cardiovascular toxicity associated with the use of NSAIDs that specifically target the enzyme cyclooxygenase 2. These findings, and others that show that inherited genetic characteristics might determine preventive success, argue for new strategies that are tailored to individual medical history and genetic make-up.

PMID:
16491072
DOI:
10.1038/nrc1801
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center